Recurrent Primary Peritoneal Carcinoma Active Not Recruiting Phase 1 / 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0031168 (Recurrent Primary Peritoneal Carcinoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03029598Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment